InMed Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

InMed Pharmaceuticals Stock Summary

InMed Pharmaceuticals competes with Quoin Pharmaceuticals, Allarity Therapeutics, Virax Biolabs, Biodexa Pharmaceticals, and LMF Acquisition. InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada. Inmed Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.

InMed Pharmaceuticals Key Financial Ratios

InMed Pharmaceuticals Key Balance Sheet Accounts

InMed Pharmaceuticals Key Income Statement Accounts

InMed Pharmaceuticals Key Cash Accounts

InMed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining InMed Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare InMed Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InMed Pharmaceuticals competition to find correlations between indicators driving InMed Pharmaceuticals's intrinsic value. More Info.InMed Pharmaceuticals is rated second overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, InMed Pharmaceuticals' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value InMed Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

InMed Pharmaceuticals Systematic Risk

Today, most investors in InMed Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various InMed Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of InMed Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of InMed Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InMed Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of InMed Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing InMed Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InMed Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InMed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if InMed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.